An outline of our cutting-edge In Vitro & In Vivo Platforms for comprehensive immuno-oncology research, providing detailed insights into immune response mechanisms and therapeutic efficacy.

These platforms enable detailed molecular and cellular analyses that enhance the translational value of preclinical studies while potentially reducing animal testing requirements.